These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 12363014

  • 1. Detection of human P-glycoprotein-like molecule in azole-resistant Candida albicans from HIV+ patients.
    Stringaro A, Molinari A, Calcabrini A, Arancia G, Ceddia PG, Cianfriglia M, Poloni F, Mondello F, Angiolella L, De Bernardis F, Cassone A.
    Microb Drug Resist; 2002; 8(3):235-44. PubMed ID: 12363014
    [Abstract] [Full Text] [Related]

  • 2. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
    Walsh TJ, Kasai M, Francesconi A, Landsman D, Chanock SJ.
    J Med Vet Mycol; 1997; 35(2):133-7. PubMed ID: 9147273
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M, Bille J.
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
    [Abstract] [Full Text] [Related]

  • 4. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
    Holmes AR, Keniya MV, Ivnitski-Steele I, Monk BC, Lamping E, Sklar LA, Cannon RD.
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients.
    Perea S, López-Ribot JL, Kirkpatrick WR, McAtee RK, Santillán RA, Martínez M, Calabrese D, Sanglard D, Patterson TF.
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2676-84. PubMed ID: 11557454
    [Abstract] [Full Text] [Related]

  • 6. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H, Dromer F, Improvisi I, Lozano-Chiu M, Rex JH, Sanglard D.
    Med Mycol; 1998 Oct; 36 Suppl 1():119-28. PubMed ID: 9988500
    [Abstract] [Full Text] [Related]

  • 7. Synergic effects of tactolimus and azole antifungal agents against azole-resistant Candida albican strains.
    Maesaki S, Marichal P, Hossain MA, Sanglard D, Vanden Bossche H, Kohno S.
    J Antimicrob Chemother; 1998 Dec; 42(6):747-53. PubMed ID: 10052898
    [Abstract] [Full Text] [Related]

  • 8. Antagonism of azole activity against Candida albicans following induction of multidrug resistance genes by selected antimicrobial agents.
    Henry KW, Cruz MC, Katiyar SK, Edlind TD.
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1968-74. PubMed ID: 10428921
    [Abstract] [Full Text] [Related]

  • 9. Antifungal activity of azole compounds CPA18 and CPA109 against azole-susceptible and -resistant strains of Candida albicans.
    Calabrese EC, Castellano S, Santoriello M, Sgherri C, Quartacci MF, Calucci L, Warrilow AG, Lamb DC, Kelly SL, Milite C, Granata I, Sbardella G, Stefancich G, Maresca B, Porta A.
    J Antimicrob Chemother; 2013 May; 68(5):1111-9. PubMed ID: 23292344
    [Abstract] [Full Text] [Related]

  • 10. Rhodamine 6G efflux for the detection of CDR1-overexpressing azole-resistant Candida albicans strains.
    Maesaki S, Marichal P, Vanden Bossche H, Sanglard D, Kohno S.
    J Antimicrob Chemother; 1999 Jul; 44(1):27-31. PubMed ID: 10459807
    [Abstract] [Full Text] [Related]

  • 11. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors.
    Sanglard D, Ischer F, Monod M, Bille J.
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2300-5. PubMed ID: 8891134
    [Abstract] [Full Text] [Related]

  • 12. [Azole resistance in Candida albicans].
    Perea S.
    Rev Esp Quimioter; 2000 Sep; 13(3):314-7. PubMed ID: 11086283
    [Abstract] [Full Text] [Related]

  • 13. The Rpd3/Hda1 family of histone deacetylases regulates azole resistance in Candida albicans.
    Li X, Cai Q, Mei H, Zhou X, Shen Y, Li D, Liu W.
    J Antimicrob Chemother; 2015 Jul; 70(7):1993-2003. PubMed ID: 25825380
    [Abstract] [Full Text] [Related]

  • 14. RTA2, a novel gene involved in azole resistance in Candida albicans.
    Jia XM, Ma ZP, Jia Y, Gao PH, Zhang JD, Wang Y, Xu YG, Wang L, Cao YY, Cao YB, Zhang LX, Jiang YY.
    Biochem Biophys Res Commun; 2008 Sep 05; 373(4):631-6. PubMed ID: 18601908
    [Abstract] [Full Text] [Related]

  • 15. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient.
    White TC, Pfaller MA, Rinaldi MG, Smith J, Redding SW.
    Oral Dis; 1997 May 05; 3 Suppl 1():S102-9. PubMed ID: 9456667
    [Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts.
    Mondello F, De Bernardis F, Girolamo A, Salvatore G, Cassone A.
    J Antimicrob Chemother; 2003 May 05; 51(5):1223-9. PubMed ID: 12668571
    [Abstract] [Full Text] [Related]

  • 17. Azole resistance in a Candida albicans mutant lacking the ABC transporter CDR6/ROA1 depends on TOR signaling.
    Khandelwal NK, Chauhan N, Sarkar P, Esquivel BD, Coccetti P, Singh A, Coste AT, Gupta M, Sanglard D, White TC, Chauvel M, d'Enfert C, Chattopadhyay A, Gaur NA, Mondal AK, Prasad R.
    J Biol Chem; 2018 Jan 12; 293(2):412-432. PubMed ID: 29158264
    [Abstract] [Full Text] [Related]

  • 18. Candida albicans Clinical Isolates from a Southwest Brazilian Tertiary Hospital Exhibit MFS-mediated Azole Resistance Profile.
    Pinto ACC, Rocha DAS, Moraes DC, Junqueira ML, Ferreira-Pereira A.
    An Acad Bras Cienc; 2019 Jul 29; 91(3):e20180654. PubMed ID: 31365653
    [Abstract] [Full Text] [Related]

  • 19. Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans.
    Marr KA, Lyons CN, Ha K, Rustad TR, White TC.
    Antimicrob Agents Chemother; 2001 Jan 29; 45(1):52-9. PubMed ID: 11120944
    [Abstract] [Full Text] [Related]

  • 20. Doxorubicin induces drug efflux pumps in Candida albicans.
    Kofla G, Turner V, Schulz B, Storch U, Froelich D, Rognon B, Coste AT, Sanglard D, Ruhnke M.
    Med Mycol; 2011 Feb 29; 49(2):132-42. PubMed ID: 20818920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.